Abstract
Purpose of Review
To investigate the effect of newer long-acting insulins on the risk of hypoglycemic episodes and fractures in people with diabetes.
Recent Findings
Hypoglycemic episodes are the critical limiting factor in glycemic management due to a deteriorating effect on quality of life. Hypoglycemia may in severe cases lead to unconsciousness and thus fractures. Newer long-acting insulins may result in more stable blood glucose levels, less hypoglycemic episodes, and reduced risk of fractures.
Summary
Use of insulin increases risk of hypoglycemic episodes, and hypoglycemic episodes increase risk of fractures plausible due to falls. Newer ultra-long-acting insulins reduce risk of hypoglycemic episodes compared to older alternatives, and they are thus promising for reducing fracture risk. However, more studies are needed to determine whether these new insulins reduce risk of fractures.
To investigate the effect of newer long-acting insulins on the risk of hypoglycemic episodes and fractures in people with diabetes.
Recent Findings
Hypoglycemic episodes are the critical limiting factor in glycemic management due to a deteriorating effect on quality of life. Hypoglycemia may in severe cases lead to unconsciousness and thus fractures. Newer long-acting insulins may result in more stable blood glucose levels, less hypoglycemic episodes, and reduced risk of fractures.
Summary
Use of insulin increases risk of hypoglycemic episodes, and hypoglycemic episodes increase risk of fractures plausible due to falls. Newer ultra-long-acting insulins reduce risk of hypoglycemic episodes compared to older alternatives, and they are thus promising for reducing fracture risk. However, more studies are needed to determine whether these new insulins reduce risk of fractures.
| Original language | English |
|---|---|
| Journal | Current Osteoporosis Reports (Print) |
| Volume | 19 |
| Pages (from-to) | 637-643 |
| ISSN | 1544-1873 |
| DOIs | |
| Publication status | Published - Dec 2021 |